SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Acquisition

29 Apr 2005 07:00

Flomerics Group PLC29 April 2005 29 April 2005 Flomerics Group plc ("the Company") Acquisition of Microelectronics Research & Development Limited Flomerics Group plc ("Flomerics" or "the Company"), supplier of virtualprototyping analysis software for the electronics industries announces theacquisition of the entire share capital of Microelectronics Research &Development Limited ("MicReD") for a maximum total consideration ofapproximately €2.1 million. Initial consideration is approximately €898,000, ofwhich €653,000 is payable in cash, the remaining €245,000 is satisfied by theissue of 250,663 Ordinary Shares of 1 pence each in the Company ("OrdinaryShares"), 80% now and 20% after 1 year. The deferred consideration is dependenton the financial performance of MicReD in 2005 and 2006. MicReD is a Hungarian based company and was formed in 1997 as a spin-off fromBudapest University of Technology. MicReD employs 13 people all located inBudapest and is led by the Chief Executive Officer, Marta Rencz. The managementteam of MicReD will all remain with the business. Its primary product is theT3Ster (pronounced Trister) - instrumentation and software used for measuringthe thermal performance of chip packages. Existing customers include Philips,Infineon, ST Microelectronics, Intel, Samsung and IBM. In the year to 31December 2004 MicReD had audited income of approximately €538,000 and made aprofit before tax of €288,000. In the previous year the unaudited turnover wasapproximately €123,000. The net assets at 31 December 2004 were €234,000. The semiconductor companies that make up the main target market for the T3Sterrepresent a significant, and strategically important, sector of the Flomerics'customer base. The use of the T3Ster enables them to evaluate and improve thethermal performance of chip-package designs - often alongside the complementaryuse of Flomerics' thermal analysis software. Just as the need for Flomerics'products is driven by the increasing miniaturisation and thermal densities ofelectronics devices - so exactly the same trends are driving the need for theT3Ster. The acquisition is thus strongly synergistic with Flomerics' current corebusiness, and represents a significant step for Flomerics towards providing acomplete thermal-design solution for its customers. In order to satisfy part of the initial consideration application has been madefor 200,530 new ordinary shares of 1p each to be admitted to trading on AIM witheffect from 5 May 2005. Following admission the issued share capital of theCompany will be 14,847,110 Ordinary Shares of 1p each. Commenting on the transaction David Tatchell, Flomerics' Chief Executive said "This is an important first step in delivering on our strategy of growing theCompany by acquisition in a way that complements our organic growth plans. I amdelighted to welcome into the Group the world-leading expertise that the MicReDteam bring. The T3Ster has many applications in markets where Flomerics is wellestablished, and we believe therefore that there is great potential to expandthe business." Marta Rencz said "We are very excited to be a part of the Flomerics group.Flomerics is the acknowledged standard setter in this field and theirinfrastructure will enable us to maximise the potential of our products." For further information please contact: David Tatchell Chief Executive 020 8487 3000Chris Ogle Finance Director & Company Secretary Buchanan Communications 020 7466 5000Tim Thompson / Nicola Cronk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Jun 20267:00 amRNSAcquisition of Helipebs Controls Ltd
28th May 20267:00 amRNS2025 Annual Report Posting & Notice of AGM
8th May 20262:28 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSAnnual Financial Report
24th Mar 20267:00 amRNSAudited Preliminary FY25 Results & Outlook update
18th Mar 20267:00 amRNSNotice of Annual results and presentation
12th Feb 20264:22 pmRNSCompletion of Acquisition
10th Feb 20264:36 pmRNSHolding(s) in Company
9th Feb 20265:25 pmRNSHolding(s) in Company
9th Feb 20264:28 pmRNSDirector/PDMR Shareholding
6th Feb 202612:08 pmRNSResult of General Meeting
22nd Jan 20264:12 pmRNSHolding(s) in Company (Correction)
22nd Jan 20262:36 pmRNSResult of Retail Offer
22nd Jan 202612:56 pmRNSHolding(s) in Company
22nd Jan 202612:48 pmRNSHolding(s) in Company
21st Jan 20262:44 pmRNSPublication of Circular
20th Jan 20263:26 pmRNSResult of Placing and Notice of General Meeting
20th Jan 20267:02 amRNSProposed Retail Offer
20th Jan 20267:01 amRNSProposed Placing And Retail Offer
20th Jan 20267:00 amRNSFull Year Trading Update & Acquisition
1st Oct 202510:39 amRNSChange of Auditor
9th Sep 20257:00 amRNSHalf-Year Report - six months ended 30 June 2025
4th Sep 20258:00 amRNSHalf-Year results - webcast presentations
29th Jul 20257:00 amRNSGroup Trading Update & Notice of Interim Results
22nd Jul 20257:00 amRNS-RNew Contract wins & Partnerships
18th Jun 20258:00 amRNS-RFlowtech wins Waterside City bridge contract
17th Jun 20252:26 pmRNSResult of AGM
27th May 20255:13 pmRNSCorrection re: timing of the 2025 AGM on 17 June
22nd May 20257:00 amRNSAvailability - FY24 Annual Report & Notice of AGM
21st May 202510:30 amRNS-RFlowtech capitalises on acquisitions opportunities
11th Apr 20257:00 amRNSDirector/PDMR Shareholding
9th Apr 20257:00 amRNSPreliminary results - year ended 31 December 2024
4th Apr 20251:19 pmRNSNotice of Results and webcast presentations
12th Feb 202511:00 amRNSDirector/PDMR Shareholding
30th Jan 20257:00 amRNSFULL YEAR TRADING UPDATE
23rd Dec 20241:53 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSPDMR - Director share dealing
26th Sep 20247:00 amRNS2024 Half-year Report & Trading update
18th Sep 20247:00 amRNSAppt of Joint Broker & Notice of Half-year results
27th Aug 20247:00 amRNSAcquisition of Thomas Wright/Thorite Group Ltd
31st Jul 20247:00 amRNSHolding(s) in Company
30th Jul 20247:00 amRNSGroup Trading Update & Notice of Interim Results
1st Jul 20247:00 amRNSChange of Adviser
19th Jun 20245:46 pmRNSHolding(s) in Company
18th Jun 20245:42 pmRNSIssue of shares to the Employees Benefit Trust
11th Jun 202412:17 pmRNSResult of AGM
31st May 202412:19 pmRNSHolding(s) in Company
22nd May 20246:03 pmRNSHolding(s) in Company
22nd May 20247:00 amRNSExercise of Warrant, Issue of new shares & TVR
20th May 20247:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.